Pete & Gerry's CEO Tom Flocco discusses how overpopulation is reducing the price of eggs for consumers, egg industry challenges, and the rise of protein. He talks with Katie Greifeld on "The Close."
Complex CEO Aaron Levant discusses teaming up with Fanatics to launch 'Complex Bets', a sports betting and trading content platform aimed at bringing pop culture to the betting and predictions market. He talks with Katie Greifeld on "The Close."
Ethan Allen Interiors Chairman, President, & CEO Farooq Kathwari discusses the impact tariffs continue to have on US retailers, and how 'cautious' consumers are still looking to buy. he talks with Katie Greifeld and Scarlet Fu on "The Close."
Center for International Policy Vice Chair Joe Cirincione discusses President Trump feeling the pressure as oil continues to surge on prolonged war fears, and why Iran should make a deal before it's 'too late.' He talks with Scarlet Fu and Katie Greifeld on "The Close"
In times of uncertainty, we often look for something solid to hold onto. Lately, it seems the world’s investors have decided that “something solid” is, quite literally, gold.
The metal’s soaring price is more than just a market trend; it's a global barometer of anxiety.
When faith in currencies, governments, and traditional financial systems begins to waver, we see a familiar flight to the perceived safety of this timeless asset.
Well, pull out the party hats and dust off the stock tickers.
Lithium, the commodity that investors and analysts had all but left for dead in the great market purge of 2023-2024, is back.
-640x360.jpg&w=1200&q=75)
The stock market has long treated Tesla (NASDAQ:TSLA) less as a traditional automaker and more as a futuristic technology cult, with its valuation soaring on the gravitational pull of its CEO, Elon Musk.
This persistent "Musk Premium" has burned countless short-sellers.
-640x360.jpg&w=1200&q=75)
Bitcoin has vaporised more than US$800 billion in its latest crash and sucked US$1 trillion out of the broader crypto market.
With nearly US$2 trillion in market value and rising allocations from Wall Street firms, ETFs, pension funds, and insurers, Bitcoin is increasingly woven into traditional finance.
The U.S. government has begun denying requests from companies seeking refunds for billions of dollars in illegal tariffs, despite a landmark Supreme Court ruling that struck down the levies last month.
Global energy markets are reeling as oil tracks toward its most significant weekly gain in four years, fuelled by escalating conflict in the Middle East.
Global oil prices held steady on March 3 as energy markets braced for an intensification of conflict in the Middle East.
U.S. Customs and Border Protection (CBP) will officially stop collecting billions in trade duties at 12:01 a.m. EST on Tuesday, following a landmark Supreme Court ruling that declared President Donald Trump’s use of emergency powers to levy tariffs illegal.
Applications for US unemployment benefits fell last week to just shy of a two-year low as Initial claims decreased by 9,000 to 202,000. Meanwhile, the US trade deficit widened in February by less than forecast on an increase in both imports and exports. Michael McKee reports on Bloomberg Television.
Lindsay (NYSE:LNN) reported a sharp decline in second-quarter profitability as a contraction in both its agricultural and infrastructure segments weighed on the top line, leading to a more than 50% drop in net earnings.
Acuity Brands (NYSE:AYI) reported a surge in second-quarter profitability and rewarded shareholders with an 18% dividend hike, as the company’s expansion into intelligent infrastructure compensated for a leaner performance in its core lighting segment.
Tesla (NASDAQ:TSLA) reported first-quarter delivery numbers that fell short of Wall Street expectations, raising fresh concerns about a widening gap between the electric vehicle maker's manufacturing pace and global consumer appetite.
ECARX Holdings (NASDAQ:ECX) achieved a historic financial turning point in the final months of 2025, reporting its first-ever quarterly net income as a public company alongside a surge in shipments for its flagship automotive computing platforms.
Merck (NYSE:MRK) has secured a landmark regulatory approval in the European Union for its blockbuster immunotherapy Keytruda, marking the region’s first PD-1 inhibitor authorized to treat a particularly aggressive form of ovarian cancer.
AstraZeneca (NASDAQ:AZN) announced positive high-level results from its EMERALD-3 Phase III trial, demonstrating that a novel combination of immunotherapies and targeted treatment significantly improved outcomes for patients with the most common form of liver cancer.
AirSculpt Technologies (NASDAQ:AIRS), a national provider of body contouring procedures, reported its fourth-quarter and full-year fiscal 2025 financial results.
Cheche Group (NASDAQ:CCG) reported its unaudited financial results for the second half and full year ended December 31, 2025, on Thursday, April 2, 2026.
Immunovant (NASDAQ:IMVT) announced topline results from two Phase 3 clinical studies evaluating batoclimab in patients with active, moderate-to-severe thyroid eye disease (TED) on Thursday, April 2, 2026.
